Loading…
Johnson & Johnson is projected to rise to $338.82 by 2027, a +27% move from its current price of $265.95. JNJ is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 29 | $262.45 | $266.06 | $269.72 | +0.04% |
| Jul 30 | $261.08 | $266.17 | $271.37 | +0.08% |
| Jul 31 | $260.06 | $266.29 | $272.66 | +0.13% |
| Aug 1 | $259.21 | $266.40 | $273.78 | +0.17% |
| Aug 2 | $258.49 | $266.51 | $274.78 | +0.21% |
| Aug 3 | $257.84 | $266.62 | $275.70 | +0.25% |
| Aug 4 | $257.26 | $266.73 | $276.55 | +0.29% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $257.26 | $266.73 | $276.55 | +0.29% |
| Week 2 | $254.18 | $267.52 | $281.55 | +0.59% |
| Week 3 | $252.02 | $268.30 | $285.65 | +0.89% |
| Week 4 | $250.32 | $269.09 | $289.28 | +1.18% |
| Week 5 | $248.92 | $269.89 | $292.61 | +1.48% |
| Week 6 | $247.74 | $270.68 | $295.75 | +1.78% |
| Week 7 | $246.71 | $271.48 | $298.73 | +2.08% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Johnson & Johnson is a healthcare company that operates worldwide with two segments: Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and cardiovascular and metabolism, distributed through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment provides a portfolio of products used in surgery, orthopedic, cardiovascular, and vision fields, distributed through wholesalers, hospitals and retailers, and used in the professional fields by physicians, nurses, hospitals, eye care professionals and clinics.
This segment also offers products and enabling technologies that support joint reconstruction, trauma, spine, sports related injuries, and others, as well as open, laparoscopic, and robotic surgical procedures; instrumentation, energy devices, stapling systems, wound closure, biosurgery products, and digital and robotic technologies; breast aesthetics and reconstruction; contact lenses under the ACUVUE brand; intraocular lenses for cataract surgery, and other products used in cataract and refractive procedures under the TECNIS brand. The company was founded in 1886 and is based in New Brunswick, New Jersey.
Johnson & Johnson launched on January 1, 1886.
Johnson & Johnson (JNJ) is a healthcare company with a current price of $265.95 and a market cap of $640.91B, ranking 15th. The stock carries a bullish longer-term outlook in the provided forecasts, with near-term nuance and a neutral start in 2026 before broad bullish momentum develops in subsequent years.
A major floor 19.2% below — a decisive break under it would weaken the trend.
The nearest floor, 14.1% below — buyers have tended to step in here.
Price is pressing into resistance (0.5% away) — a breakout level to watch.
A major ceiling 10.1% above — clearing it would confirm fresh momentum.
Key JNJ support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of JNJ market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $258.97 | Buy | $260.45 | Buy |
| MA 10 | $254.76 | Buy | $257.65 | Buy |
| MA 20 | $257.04 | Buy | $254.34 | Buy |
| MA 50 | $242.64 | Buy | $246.46 | Buy |
| MA 100 | $238.85 | Buy | $238.72 | Buy |
| MA 200 | $225.02 | Buy | $224.60 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 64.49 | Neutral |
| Stoch RSI (14) | 84.36 | Sell |
| CCI (20) | 127.49 | Buy |
| Williams %R (14) | 0.00 | Info |
| MACD (12,26,9) | 0.19 | Buy |
| ROC (12) | 2.64 | Buy |
| Bollinger %B (20,2) | 0.90 | Neutral |
| Stochastic %K (14) | 100.00 | Sell |
| TRIX (15) | 0.28 | Buy |
| Awesome (5,34) | 9.79 | Buy |
| Ultimate (7,14,28) | 70.26 | Sell |
| Momentum (10) | 8.18 | Buy |
| Aroon Osc (25) | 44.00 | Buy |
| Hull MA (9) | 264.57 | Buy |
| ADX (14) | 19.21 | Neutral |
| ATR (14) | 3.68 | Info |
Technical picture for the last 30 days shows bullish sentiment with RSI(14) at 60. The 50-day simple moving average is $242.64 and the 200-day simple moving average is $225.02. A key support level is at $228.39 and a key resistance level is at $267.24.
The most recent 30-day trading range spans from $243.04 to $291.02, reflecting tighter ranges around the current price.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $204.31 | $265.95 | $351.47 | 0% | Neutral | |
| $277.76 | $338.82 | $431.92 | +27% | Bullish | |
| $322.55 | $400.93 | $525.11 | +51% | Bullish | |
| $394.30 | $497.73 | $665.89 | +87% | Bullish | |
| $427.81 | $547.37 | $745.57 | +106% | Bullish | |
| $454.35 | $588.45 | $814.26 | +121% | Bullish | |
| $503.39 | $659.35 | $925.42 | +148% | Bullish | |
| $522.25 | $691.29 | $982.85 | +160% | Bullish | |
| $624.35 | $834.66 | $1,200.93 | +214% | Bullish | |
| $743.12 | $1,002.88 | $1,459.07 | +277% | Bullish | |
| $997.04 | $1,403.49 | $2,140.05 | +428% | Bullish | |
| $1,929.47 | $2,913.11 | $4,761.91 | +995% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $204.31 | $265.95 | $311.36 | +0.00% |
| August 2026 | $233.56 | $272.52 | $324.19 | +2.47% |
| September 2026 | $235.52 | $276.33 | $331.71 | +1.40% |
| October 2026 | $232.44 | $273.94 | $331.24 | -0.86% |
| November 2026 | $234.92 | $277.90 | $338.02 | +1.44% |
| December 2026 | $242.13 | $287.40 | $351.47 | +3.42% |
Click any year to see its month-by-month JNJ forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Johnson & Johnson's 2026 outlook centres on $265.95, within a $204.31 to $351.47 range. That marks a 0% change versus current levels. A consolidation phase looks the most probable path here.
By 2027, JNJ could reach as high as $431.92, with a base case around $338.82 and support toward $277.76 — roughly +27% from $265.95. Momentum favours further upside here.
Expect JNJ to range from $322.55 to $525.11 through 2028. The $400.93 average target implies a +51% move from current prices. That is up +18% on the projected 2027 average. Buyers look set to stay in control over this stretch.
The JNJ price prediction for 2029 points to an average of $497.73 (low $394.30, high $665.89) — a potential gain of +87% on today's $265.95. Momentum favours further upside here.
In 2030, JNJ is projected to trade between $427.81 and $745.57, averaging $547.37 — a potential gain of +106% from today's $265.95. That is up +10% on the projected 2029 average. Buyers look set to stay in control over this stretch.
Johnson & Johnson's 2031 outlook centres on $588.45, within a $454.35 to $814.26 range. That is up +8% on the projected 2030 average. That marks a +121% change versus current levels. Momentum favours further upside here.
By 2032, JNJ could reach as high as $925.42, with a base case around $659.35 and support toward $503.39 — roughly +148% from $265.95. Buyers look set to stay in control over this stretch.
Expect JNJ to range from $522.25 to $982.85 through 2033. The $691.29 average target implies a +160% move from current prices. That is up +5% on the projected 2032 average. Momentum favours further upside here.
The JNJ price prediction for 2034 points to an average of $834.66 (low $624.35, high $1,200.93) — a potential gain of +214% on today's $265.95. Buyers look set to stay in control over this stretch.
In 2035, JNJ is projected to trade between $743.12 and $1,459.07, averaging $1,002.88 — a potential gain of +277% from today's $265.95. That is up +20% on the projected 2034 average. Momentum favours further upside here.
Johnson & Johnson's 2040 outlook centres on $1,403.49, within a $997.04 to $2,140.05 range. That is up +40% on the projected 2035 average. That marks a +428% change versus current levels. Buyers look set to stay in control over this stretch.
By 2050, JNJ could reach as high as $4,761.91, with a base case around $2,913.11 and support toward $1,929.47 — roughly +995% from $265.95. Momentum favours further upside here.
Investing $1,000 in JNJ today (≈ 3.760105 JNJ) could be worth
$10,953.59
+$9,953.59 (+995%) by 2050 · US Dollar
Based on the average projected JNJ price of $2,913.11 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in JNJwould be worth at today's price.
$1,000 invested in JNJ on Jul 28, 2025 (≈ 6.016123 JNJ) would be worth
$1,599.99
+$599.99 (+60.0%) today · 1.60× · US Dollar
Based on a JNJ entry price of $166.22 vs. today's $265.95.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $248.82 | $1,068.84 | +6.9% |
| 1 month ago | $254.66 | $1,044.33 | +4.4% |
| 3 months ago | $227.79 | $1,167.52 | +16.8% |
| 6 months ago | $227.72 | $1,167.88 | +16.8% |
| 1 year ago | $166.22 | $1,599.99 | +60.0% |
| All time (5.0y) ago | $172.18 | $1,544.6 | +54.5% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our JNJ forecast.
Our base-case forecast reaches $530.00 around 2030.
Implied market cap at $530.00: $1.28T
Forecasts project multi-year upside with rising averages and outsized max values. For 2026 the min is $204.31, the avg is $265.95, and the max is $351.47 with a neutral sentiment. From 2027 onward, the outlook turns bullish with the following highlights: 2027—min $277.76, avg $338.82, max $431.92, ROI 27.4%; 2028—min $322.55, avg $400.93, max $525.11, ROI 50.8%; 2029—min $394.30, avg $497.73, max $665.89, ROI 87.2%; 2030—min $427.81, avg $547.37, max $745.57, ROI 105.8%; 2031—min $454.35, avg $588.45, max $814.26, ROI 121.3%; 2032—min $503.39, avg $659.35, max $925.42, ROI 147.9%; 2033—min $522.25, avg $691.29, max $982.85, ROI 159.9%; 2034—min $624.35, avg $834.66, max $1,200.93, ROI 213.8%; 2035—min $743.12, avg $1,002.88, max $1,459.07, ROI 277.1%; 2040—min $997.04, avg $1,403.49, max $2,140.05, ROI 427.7%; 2050—min $1,929.47, avg $2,913.11, max $4,761.91, ROI 995.4%.
Overall sentiment across the forecast is BULLISH, with substantial long-term upside despite the neutral start in 2026.
Tap a question to reveal the answer.
The 2030 forecast shows min $427.81, avg $547.37, max $745.57 with ROI 105.8% and a BULLISH sentiment.
Near term starts neutral in 2026 with avg $265.95, then from 2027 onward the forecast is bullish with rising averages and ROIs up to 105.8% by 2030 and up to 995.4% by 2050.
Yes. The 2035 max is $1,459.07 and the 2035 average is $1,002.88, indicating a path above $1,000 in the mid-2030s.
Current price: $265.95. Market cap: $640.91B.
RSI(14) is 60 with a bullish tilt. The 50-day SMA is $242.64 and the 200-day SMA is $225.02. Support is at $228.39 and resistance at $267.24. The 30-day trading range spans from $243.04 to $291.02, and annualized volatility is 30%.
Johnson & Johnson Community Discussion
0Share your Johnson & Johnson price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.